-
Semaglutide-associated Vision Loss Due to NAION – New Medical Report, May 2026
Ozempic, Wegovy, and Rybelsus Are Semaglutide Drugs Linked to Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) (Posted by Tom Lamb at Drug Injury Watch) Before we direct you to a new medical report about semaglutide-associated vision loss due…
-
Ozempic And Other GLP-1RA Use Associated With NAION Eye Side Effect
New 2026 Medical Article Published By JAMA Network Open Investigates Drug Safety Issue (Posted by Tom Lamb at Drug Injury Watch) An increasingly known but still-developing drug safety issue is that of Ozempic and other GLP-1RA use…
-
Tavneos Warnings For VBDS Liver Side Effect Increased In April 2026
Tavneos Drug Label Change By Amgen Just 2 Days After Tavneos Drug Recall Statement By FDA (Posted by Tom Lamb at Drug Injury Watch) The Tavneos drug safety issue has an interesting new development. On April 29,…
-
Tavneos Liver Injury Drug Safety Communication Issued by FDA in Late March 2026
Just 2 Months Earlier, Amgen Refused an FDA Request to Withdraw Tavneos; Will There Be a Tavneos Recall Soon? (Posted by Tom Lamb at Drug Injury Watch) On March 31, 2026, the FDA issued a Tavneos liver…
-
Wegovy and Ozempic Vision Loss: Wegovy Rate 5x Higher vs. Ozempic, Men 3x More Often vs. Women
Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) Semaglutide Study 2026 Data Analysis (Posted by Tom Lamb at Drug Injury Watch) A March 2026 British Journal of Ophthalmology medical journal article, “Ischemic optic neuropathy with semaglutide: global observational analysis…
Free. Confidential. No Obligation.
Free Case Evaluation
We encourage you to submit a Drug Injury Case Evaluation Form online – it is free, confidential, and there is no obligation. Or, if you prefer, call 910-256-2971 to speak directly to attorney Tom Lamb about a possible drug injury lawsuit. Either way, you will get Mr. Lamb’s impressions about your possible case, and the benefit of his over 25 years of experience handling drug injury cases.
About the Law Offices of Thomas J. Lamb
The Law Offices of Thomas J. Lamb has been representing patients and their families in drug injury lawsuits throughout the country for more than 25 years.
Drug injury cases involve personal injury claims or wrongful death claims filed on behalf of people who experienced unwanted side effects or a serious adverse reaction caused by a prescription drug. Some unsafe drugs have been the subject of government warnings or a drug recall, while other drugs remain on the market with black box warnings and continue to be prescribed by doctors today.
Given the many years of experience attorney Tom Lamb has handling these types of lawsuits, we know drug injury cases deserve special attention.
Drug injury claims have a personal aspect that must be appreciated and respected by the lawyer handling your case. At our firm, it is not class actions. Rather, we always file an individual case lawsuit. With this approach, you will get personal attention, and the lawsuit is only about your specific case. An individual lawsuit for your drug injury case is better from start to finish.
The Law Offices of Thomas J. Lamb will handle your drug injury case competently and professionally, as well as with genuine care and understanding. As our client, your email inquiries are responded to promptly, and telephone calls are always returned without delay if we are not available immediately.
We encourage you to submit a Drug Injury Case Evaluation Form – it is free, confidential, and there is no obligation. Or, if you prefer, you can call 910-256-2971 and speak directly to attorney Tom Lamb about a possible drug injury case. Either way, you will get Mr. Lamb’s impressions — not an intake person, a paralegal, or some other lawyer — about your case based on his many years of experience.
In closing, at the Law Offices of Thomas J. Lamb, we understand that you have options when it comes to finding the right law firm to handle your case.
Please know that we look forward to working on your behalf.
Tom Lamb
Handling drug injury cases since 1999